2007Journal of clinical and experimental medicineRequires access

Diagnostic value of combined detection of serum CEA, CA19-9 and CA72-4 in colorectal carcinomas

Qiufang Huang

Open publisher page 0 citations

Abstract

Objective To explore the diagnostic value of colorectal carcinomas by combined detection of the preoperative serum CEA,CA19-9 and CA72-4.Methods Serum levels of CEA,CA19-9 and CA72-4 in 173 cases of colorectal carcinomas and 44 cases of benign colorectal diseases were determined by using electro-chemiluminescence immunoassay (ECLIA).Results The results showed that the serum levels of CEA,CA19-9 and CA72-4 were significantly higher in the colorectal carcinoma group than those in the benign colorectal diseases group (P0.01).The positive rate of CEA,CA19-9 and CA72-4 in combination was 54.9%, higher than the combination of CEA and CA72-4 (52.6%) ,CEA and CA19-9 (50.9%), and CA19-9 and CA72-4 (28.3%).Conclusion Appropriate combination of tumor markers may raise positive rates in diagnosing colorectal cancer. For saving money, CEA alone or the combination of CEA and CA72-4 are the choice of detection.

About this research paper

What this paper is about

Objective To explore the diagnostic value of colorectal carcinomas by combined detection of the preoperative serum CEA,CA19-9 and CA72-4.Methods Serum levels of CEA,CA19-9 and CA72-4 in 173 cases of colorectal carcinomas and 44 cases of benign colorectal diseases were determined by using electro-chemiluminescence immunoassay (ECLIA).Results The results showed that the serum levels of CEA,CA19-9 and CA72-4 were significantly higher in the colorectal carcinoma group than those in the benign colorectal diseases group (P0.01).The positive rate of CEA,CA19-9 and CA72-4 in combination was 54.9%, higher than the combination of CEA and CA72-4 (52.6%) ,CEA and CA19-9 (50.9%), and CA19-9 and CA72-4 (28.3%).Conclusion Appropriate combination of tumor markers may raise positive rates in diagnosing colorectal cancer. For saving money, CEA alone or the combination of CEA and CA72-4 are the choice of detection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the diagnostic value of colorectal carcinomas by combined detection of the preoperative serum CEA,CA19-9 and CA72-4.Methods Serum levels of CEA,CA19-9 and CA72-4 in 173 cases of colorectal carcinomas and 44 cases of benign colorectal diseases were determined by using electro-chemiluminescence immunoassay (ECLIA).Results The results showed that the serum levels of CEA,CA19-9 and CA72-4 were significantly higher in the colorectal carcinoma group than those in the benign colorectal diseases group (P0.01).The positive rate of CEA,CA19-9 and CA72-4 in combination was 54.9%, higher than the combination of CEA and CA72-4 (52.6%) ,CEA and CA19-9 (50.9%), and CA19-9 and CA72-4 (28.3%).Conclusion Appropriate combination of tumor markers may raise positive rates in diagnosing colorectal cancer. For saving money, CEA alone or the combination of CEA and CA72-4 are the choice of detection.

Key concepts: Medicine, CA19-9, Colorectal cancer, Internal medicine, Oncology, Gastroenterology, Cancer, Pancreatic cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Diagnostic value of combined detection of serum CEA, CA19-9 and CA72-4 in colorectal carcinomas — Research Paper | ScholarLens